Synergio Overview
Synergio is focused on reshaping the consumer goods industry with smart ingredients for healthy, sustainable products. The company’s patented micro-targeting technology is designed to enable all-natural ingredients to achieve their desired effects without side effects. Using a data-driven computational platform, Synergio leverages a deep understanding of plants in order to accelerate health and sustainability worldwide. Synergio’s smart ingredients are 100% natural with no chemical modifications, and its synergistic plant bioactive combinations are readily or inherently biodegradable and environmentally benign.
Cumulative Funding Raised Over Time ($)
$15.0MDec 2019
$15.0MFeb 2023
$25.0MJun 2020
Latest News
growth-positive
Symrise invests in natural antimicrobials with minority stake in Synergio
Cosmetic ingredients maker Symrise has invested in Synergio, a Jerusalem-based biotech company. Symrise will acquire a minority ownership in Synergio with the possibility to acquire a majority stake in the future. The two companies will work together as partners to develop innovative antimicrobial solutions. Other beauty companies have also invested in biotech firms to tap into their expertise.
Partners
growth-positive
Mother's Choice announces $10 million raise led by foreign investors
Jerusalem-based personal care products company, Mother’s Choice, has raised $10 million in a funding round led by private foreign investors, including institutional investors from New York and Connecticut. The funds will be used to expand the company’s sales in the U.S. and Europe, grow its product range, and build its intellectual property. The company also announced the appointment of Itamar Levi as its new CEO. Mother’s Choice, which was founded in 2007, develops natural and safe technology for the food and personal care sectors and cooperates with industry leaders like Unilever, Colgate-Palmolive, and Proctor & Gamble.
InvestmentManagement Changes
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $25.5M |
| Last funding | Undisclosed |
| Stage | A |
| Rounds | 4 |
| Investors | 6 |
Team Members
3
Employees: 11-50
Web & Social Links
| Website | synergio.com/ |
| Careers | Careers page |
Locations
Givat Ram, Jerusalem, Israel
Photos & Videos
No files yet
Synergio Business
Business models
B2B2C, B2B
Product stage
R&D
Employees
11-50
Sector
Climate TechClean Industry Tech Sustainable Materials & CircularityFood & Land UseSustainable FarmingAgriculture & Food TechnologiesFood TechFood ProcessingFood Trade & ServicesHealth Tech & Life SciencesPharma & Medical BiotechnologyCosmetic MaterialsDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesCosmeticsPharmaceuticalsAgriculture & FoodProcessed FoodsIngredientsCore Technology
BiologicalsMoleculesArtificial IntelligenceMaterials & SubstancesRaw MaterialsTags (12)
pharmaceuticalsbabieschildrencosmeticsseniorsclimate-techfoodtechfood-ingredientshome-carefood-and-beveragenovel-ingredientsindustrial-technologiesGeographic Markets
GlobalSynergio Financials
$25.5M
Total funding
Undisclosed
Capital raised
Undisclosed
Last funding
A
Funding stage
4
Total rounds
6
Investors
Cumulative Funding Raised Over Time ($)
$15.0MDec 2019
$15.0MFeb 2023
$25.0MJun 2020
Private Equity Funding
Undisclosed Round
Feb 2023
Undisclosed
Symrise (Lead)
A Round
Jun 2020
$10M
Connecticut Innovations (Lead)
,
Safer Made, VentureClash, Undisclosed Investor(s), Kli Capital
Seed
Dec 2019
$15M
Undisclosed Investor(s)
Non-Equity Funding
GrantEvent
Oct 2019
$500K
VentureClash
Synergio Lifecycle
Cumulative Funding Raised Over Time
$15.0MDec 2019
$15.0MFeb 2023
$25.0MJun 2020
All Events
Undisclosed Round
Feb 2023
Undisclosed
Symrise (Lead)
A Round
Jun 2020
$10M
Connecticut Innovations (Lead)
,
Safer Made, VentureClash, Undisclosed Investor(s), Kli Capital
Seed
Dec 2019
$15M
Undisclosed Investor(s)
GrantEvent
Oct 2019
$500K
VentureClash
Synergio News
2 articles
growth-positive
Symrise invests in natural antimicrobials with minority stake in Synergio
Cosmetic ingredients maker Symrise has invested in Synergio, a Jerusalem-based biotech company. Symrise will acquire a minority ownership in Synergio with the possibility to acquire a majority stake in the future. The two companies will work together as partners to develop innovative antimicrobial solutions. Other beauty companies have also invested in biotech firms to tap into their expertise.
Partners
growth-positive
Mother's Choice announces $10 million raise led by foreign investors
Jerusalem-based personal care products company, Mother’s Choice, has raised $10 million in a funding round led by private foreign investors, including institutional investors from New York and Connecticut. The funds will be used to expand the company’s sales in the U.S. and Europe, grow its product range, and build its intellectual property. The company also announced the appointment of Itamar Levi as its new CEO. Mother’s Choice, which was founded in 2007, develops natural and safe technology for the food and personal care sectors and cooperates with industry leaders like Unilever, Colgate-Palmolive, and Proctor & Gamble.
InvestmentManagement Changes
Synergio Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 11 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 27 classification IDs that could be used for matching.
Synergio Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 90/100 |
| Missing | video or image, markets, not claimed |
| BI Verification | Sharon Shapira |
| Registrar ID | 513946160 |
| Crunchbase | mother-s-choice |
| Phone | +97225610752 |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-06-30T00:00:00.000Z |
| Created | 2014-11-10T00:00:00.000Z |